Log into the BADBIR Database
BADBIR News
- 1/6 Visit us at the BDNG Annual Conference 2025 in Harrogate!
- 2/6 Recruitment to Taltz has ended
- 3/6 Read more: Changes to conventional cohort eligibility criteria
- 4/6 Our new 2025 Annual Update is available to read here
- 5/6 Patients diagnosed with Generalised Pustular Psoriasis are eligible on Spevigo (spesolimab) or conventional treatment
- 6/6 Reminder that we currently recruit for patients on Sotyktu (deucravacitinib)
Find out more on our website.